Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-13-016705
Filing Date
2013-03-21
Accepted
2013-03-21 17:09:30
Documents
7
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v338546_10-ka.htm 10-K/A 68506
  Complete submission text file 0001144204-13-016705.txt   6659968

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT navb-20121231.xml EX-101.INS 886804
3 XBRL TAXONOMY EXTENSION SCHEMA navb-20121231.xsd EX-101.SCH 79964
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE navb-20121231_cal.xml EX-101.CAL 76396
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE navb-20121231_def.xml EX-101.DEF 309339
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE navb-20121231_lab.xml EX-101.LAB 1044770
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE navb-20121231_pre.xml EX-101.PRE 491802
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35076 | Film No.: 13708320
SIC: 2835 In Vitro & In Vivo Diagnostic Substances